...for drug companies. "We've seen multiple drug companies in the past year or two paying big chunks to states to reimburse them," said Dr. Jon LeCroy, an analyst who follows Lilly for Natixis Bleichroeder Inc. "It's just expected."

...they're "just a part of doing business," according to Dr. Jon LeCroy, an analyst who covers Lilly for Natixis Bleichroeder Inc. "A $15 million settlement to make it go away for a company that size is really not that big a deal," LeCroy...